Biodesix Inc (BDSX)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | Mr. John PatienceIndependent Chairman | 1.36k | 0.00 | Derivative Exercise and Retained Stock | - | 375.82k | 0.36% |
| 2026-02-20 | Mr. Christopher VazquezVP & Controller | 352.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.59k | 28.53% |
| 2026-02-20 | Mr. Christopher VazquezVP & Controller | -211.00 | 2.70k | Derivative Exercise and Sale | 12.78 | 1.59k | - |
| 2026-02-20 | Mr. Scott HuttonPresident, CEO & Director | 3.35k | 0.00 | Derivative Exercise and Retained Stock | - | 48.77k | 7.39% |
| 2026-02-20 | Mr. Scott HuttonPresident, CEO & Director | -1.49k | 19.04k | Derivative Exercise and Sale | 12.78 | 48.77k | - |
| 2026-02-20 | Dr. Gary Anthony PestanoChief Scientific Officer | 972.00 | 0.00 | Derivative Exercise and Retained Stock | - | 10.36k | 10.35% |
| 2026-02-20 | Dr. Gary Anthony PestanoChief Scientific Officer | -556.00 | 7.10k | Derivative Exercise and Sale | 12.78 | 10.36k | - |
| 2026-02-20 | Mr. Kieran O'KaneChief Commercial Officer | 934.00 | 0.00 | Derivative Exercise and Retained Stock | - | 9.82k | 10.51% |
| 2026-02-20 | Mr. Kieran O'KaneChief Commercial Officer | -535.00 | 6.83k | Derivative Exercise and Sale | 12.78 | 9.82k | - |
| 2026-02-20 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | 934.00 | 0.00 | Derivative Exercise and Retained Stock | - | 16.23k | 6.11% |
| 2026-02-20 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | -535.00 | 6.83k | Derivative Exercise and Sale | 12.78 | 16.23k | - |
| 2026-02-09 | Mr. Scott HuttonPresident, CEO & Director | 6.44k | 0.00 | Derivative Exercise and Retained Stock | - | 45.41k | 16.52% |
| 2026-02-09 | Mr. Scott HuttonPresident, CEO & Director | -3.56k | 35.89k | Derivative Exercise and Sale | 10.08 | 45.41k | - |
| 2026-02-09 | Mr. Kieran O'KaneChief Commercial Officer | 1.02k | 0.00 | Derivative Exercise and Retained Stock | - | 8.89k | 12.91% |
| 2026-02-09 | Mr. Kieran O'KaneChief Commercial Officer | -584.00 | 5.89k | Derivative Exercise and Sale | 10.08 | 8.89k | - |
| 2026-02-09 | Dr. Gary Anthony PestanoChief Scientific Officer | 941.00 | 0.00 | Derivative Exercise and Retained Stock | - | 9.39k | 11.14% |
| 2026-02-09 | Dr. Gary Anthony PestanoChief Scientific Officer | -540.00 | 5.45k | Derivative Exercise and Sale | 10.08 | 9.39k | - |
| 2026-02-09 | Mr. Christopher VazquezVP & Controller | 162.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.23k | 15.11% |
| 2026-02-09 | Mr. Christopher VazquezVP & Controller | -101.00 | 1.02k | Derivative Exercise and Sale | 10.08 | 1.23k | - |
| 2026-02-09 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | 1.64k | 0.00 | Derivative Exercise and Retained Stock | - | 15.30k | 12.03% |
| 2026-02-09 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | -941.00 | 9.49k | Derivative Exercise and Sale | 10.08 | 15.30k | - |
| 2026-01-23 | Mr. Jack W. SchulerIndependent Director | 100.00k | 1.18M | 買い | 11.80 - 11.81 | 2.31M | 4.52% |
| 2026-01-22 | Mr. Jack W. SchulerIndependent Director | 82.47k | 903.56k | 買い | 10.96 | 2.21M | 3.87% |
| 2026-01-15 | Mr. Kieran O'KaneChief Commercial Officer | 507.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.87k | 6.89% |
| 2026-01-15 | Mr. Kieran O'KaneChief Commercial Officer | -298.00 | 2.43k | Derivative Exercise and Sale | 8.15 | 7.87k | - |
| 2026-01-15 | Dr. Gary Anthony PestanoChief Scientific Officer | 507.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.45k | 6.39% |
| 2026-01-15 | Dr. Gary Anthony PestanoChief Scientific Officer | -298.00 | 2.43k | Derivative Exercise and Sale | 8.15 | 8.45k | - |
| 2026-01-15 | Mr. Christopher VazquezVP & Controller | 136.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.07k | 14.53% |
| 2026-01-15 | Mr. Christopher VazquezVP & Controller | -83.00 | 676.39 | Derivative Exercise and Sale | 8.15 | 1.07k | - |
| 2026-01-15 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | 507.00 | 0.00 | Derivative Exercise and Retained Stock | - | 13.65k | 3.86% |
| 2026-01-15 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | -298.00 | 2.43k | Derivative Exercise and Sale | 8.15 | 13.65k | - |
| 2026-01-15 | Mr. Scott HuttonPresident, CEO & Director | 1.66k | 0.00 | Derivative Exercise and Retained Stock | - | 38.97k | 4.46% |
| 2026-01-15 | Mr. Scott HuttonPresident, CEO & Director | -970.00 | 7.90k | Derivative Exercise and Sale | 8.15 | 38.97k | - |
| 2026-01-05 | Mr. John PatienceIndependent Chairman | 1.14k | 0.00 | Derivative Exercise and Retained Stock | - | 25.31k | 4.73% |
| 2025-11-10 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | 108.00 | 0.00 | Derivative Exercise and Retained Stock | - | 13.15k | 0.83% |
| 2025-11-10 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | -50.00 | 381.00 | Derivative Exercise and Sale | 7.62 | 13.15k | - |
| 2025-11-10 | Dr. Gary Anthony PestanoChief Scientific Officer | 46.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.94k | 0.58% |
| 2025-11-10 | Dr. Gary Anthony PestanoChief Scientific Officer | -23.00 | 175.26 | Derivative Exercise and Sale | 7.62 | 7.94k | - |
| 2025-11-10 | Mr. Scott HuttonPresident, CEO & Director | 422.00 | 0.00 | Derivative Exercise and Retained Stock | - | 37.31k | 1.14% |
| 2025-11-10 | Mr. Scott HuttonPresident, CEO & Director | -189.00 | 1.44k | Derivative Exercise and Sale | 7.62 | 37.31k | - |
| 2025-11-10 | Mr. Kieran O'KaneChief Commercial Officer | 50.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.36k | 0.68% |
| 2025-11-10 | Mr. Kieran O'KaneChief Commercial Officer | -25.00 | 190.50 | Derivative Exercise and Sale | 7.62 | 7.36k | - |
| 2025-11-10 | Mr. Christopher VazquezVP & Controller | 18.00 | 0.00 | Derivative Exercise and Retained Stock | - | 936.00 | 1.96% |
| 2025-11-10 | Mr. Christopher VazquezVP & Controller | -13.00 | 99.06 | Derivative Exercise and Sale | 7.62 | 936.00 | - |
| 2025-09-30 | Mr. John PatienceIndependent Chairman | 1.14k | 0.00 | Derivative Exercise and Retained Stock | - | 373.31k | 0.31% |
| 2025-09-19 | Mr. Jack W. SchulerIndependent Director | 142.05k | 1,000.00k | 買い | 7.04 | 2.13M | 7.14% |
| 2025-09-17 | Mr. Jack W. SchulerIndependent Director | 18.37k | 111.43k | 買い | 6.04 - 6.17 | 1.99M | 0.93% |
| 2025-08-29 | Mr. Jack W. SchulerIndependent Director | 174.42k | 1.50M | 買い | 8.60 | 1.97M | 9.71% |
| 2025-08-12 | Dr. Gary Anthony PestanoChief Scientific Officer | 46.85 | 0.00 | Derivative Exercise and Retained Stock | - | 7.89k | 0.60% |
| 2025-08-12 | Dr. Gary Anthony PestanoChief Scientific Officer | -22.10 | 184.00 | Derivative Exercise and Sale | 8.33 | 7.89k | - |
| 2025-08-12 | Mr. Kieran O'KaneChief Commercial Officer | 50.65 | 0.00 | Derivative Exercise and Retained Stock | - | 7.00k | 0.73% |
| 2025-08-12 | Mr. Kieran O'KaneChief Commercial Officer | -23.80 | 198.16 | Derivative Exercise and Sale | 8.33 | 7.00k | - |
| 2025-08-12 | Mr. Scott HuttonPresident, CEO & Director | 422.00 | 0.00 | Derivative Exercise and Retained Stock | - | 36.44k | 1.17% |
| 2025-08-12 | Mr. Scott HuttonPresident, CEO & Director | -188.60 | 1.57k | Derivative Exercise and Sale | 8.33 | 36.44k | - |
| 2025-08-12 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | 108.45 | 0.00 | Derivative Exercise and Retained Stock | - | 12.54k | 0.87% |
| 2025-08-12 | Ms. Robin Harper CowieCFO, Secretary & Treasurer | -49.40 | 411.30 | Derivative Exercise and Sale | 8.33 | 12.54k | - |
| 2025-08-12 | Mr. Christopher VazquezVP & Controller | 18.70 | 0.00 | Derivative Exercise and Retained Stock | - | 919.00 | 2.08% |
| 2025-08-12 | Mr. Christopher VazquezVP & Controller | -11.40 | 94.92 | Derivative Exercise and Sale | 8.33 | 919.00 | - |
| 2025-06-30 | Mr. John PatienceIndependent Chairman | 1.14k | 0.00 | Derivative Exercise and Retained Stock | - | 372.17k | 0.31% |
| 2025-07-01 | Mr. Hany MassaranyIndependent Director | 1.32k | 0.00 | Derivative Exercise and Retained Stock | - | 18.18k | 7.82% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。